AstraZeneca
Company and Pharmaceutical Company
Diplomas in science 'cannot work'...for young people. These include universities, employers and practitioners, as well as influential members of the science community such as science academics from Oxford University, Imperial College, AstraZeneca and the NHS. It was and is... In this article: Royal Society, Institute of Physics, Imperial College, Oxford University, Confederation of British Industry, and AstraZeneca |
-
Medical News Today | May 28, 2009
Celleron Therapeutics And Astrazeneca Announce Personalised Medicine Collaboration In Cancer For The Development Of AZ's Leading HDAC Inhibitor
...future juncture. John Goddard, SVP of Strategic Planning and Business Development at AstraZeneca commented that; "We are very pleased to enter into this innovative and flexible agreement with Celleron Therapeutics. We have strong respect...
In this article: AstraZeneca plc, Cancer, Breast cancer, Oxford University, Medical advice, Competitive advantage, and Strategic planning
-
jiplp.oxfordjournals.org
The Commission's AstraZeneca decision: delaying generic entry ...
Oxford Journals. Contact Us. My Basket. My Account. Journal of ... Site Map. Privacy Policy. Frequently Asked Questions. Other Oxford University Press sites: ...
-
clinicaltrials.gov
Efficacy and Safety of Adding Clopidogrel to Aspirin or Use ...
AstraZeneca. Information provided by: University of Oxford. ClinicalTrials.gov Identifier: ... Study Chair: Rory Collins, Msc. University of Oxford. Study Chair: ...
-
cardiovascres.oxfordjournals.org
Fractalkine has Anti-apoptotic and Proliferative Effects on ...
2 Bioscience Dept, CVGI, AstraZeneca R&D Mölndal, Pepparedsleden 1, ... Copyright © 2009 European Society of Cardiology. Oxford Journals Oxford University Press ...
-
www.oxfordstudent.com
The Oxford Student
... as "the consultancy arm of the University of Oxford" on its website. ... been released by the University are: Astra Zeneca, BAE Systems, BASF, Bayer Schering ...
-
www.astrazeneca.com
AstraZeneca International - pharmaceutical company ...
AstraZeneca corporate information, one of the world's leading pharmaceutical ... University of Oxford, the Karolinska Institutet (Sweden), Munster University ...
-
www.chemeurope.com
Tagging-detagging for purification of radiotracers
Tagging-detagging for purification of radiotracers, : Veronique Gouverneur and colleagues from the University of Oxford and AstraZeneca, Cheshire, have developed a ...
-
www.pharmiweb.com
CELLERON THERAPEUTICS AND ASTRAZENECA ANNOUNCE PERSONALISED ...
Celleron Therapeutics Ltd, the Oxford UK based specialist in the development of individually targeted cancer medicines, ... at Oxford University added; ...
-
kn.theiet.org
People and contacts - The IET
Cambridge University. Jonathan Swinton. AstraZeneca. Mattias Rantalainen. Department of Statistics, University of Oxford. Vincent Rouilly ...
Trends
Loading...
More on AstraZeneca
Description from Wikipedia:
AstraZeneca plc (LSE: AZN, , NYSE: AZN), is a large Anglo-Swedish pharmaceutical company formed on 6 April 1999 by the remerger of Swedish Astra AB and British Zeneca Group plc. Zeneca had been part of Imperial Chemical Industries, as 3 divisions that were spun off from ICI on 1 June 1993. The Company is listed on the London Stock Exchange and is a constituent of the FTSE 100 Index.
- Name:
- AstraZeneca plc
- Type:
- Public LSE, NYSE and OMX: AZN
- Location:
- London, United Kingdom
- Founded:
- 6 April 1999 by merger
- Stock Symbol:
- AZN
- Industry:
- Pharmaceutical
- Key People:
-
- Louis Schweitzer, Chairman
- David R. Brennan, CEO
- Products:
- Pharmaceutical products for humans
- Revenue:
- $31.601 billion (2008)
- Operating Income:
- $9.144 billion (2008)
- Net Income:
- $6.130 billion (2008)
- No. of Employees:
- 66,100 (2008)
- Motto:
- Life inspiring ideas.
Explore everything named AstraZeneca...
